Vice President, Value, Market Access & Pricing, Europe

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

We are preparing for the global commercialization of our first product, addressing a significant unmet medical need with the first target indication being Pancreatic Cancer. As we build our European organization, we are seeking a visionary leader to lead the European Value, Market Access & Pricing team. This position will lead the development and execution of our European market access and pricing strategies, tools and resources to support optimal access for pipeline assets.  In addition to shaping access strategies, the leader will collaborate closely with Country teams and work closely with the Global Value, Access and Pricing, HEOR, and Medical Affairs teams.

This leader will shape and lead value and access submission and negotiation planning, including optimal country launch sequence and ensure sustainable access in key European markets. Reporting to the SVP, European GM, this role will be a core member of the Europe Region leadership team, working cross-functionally to influence long-term growth, patient impact, and company valuation.

Responsibilities:

Europe Value, Access & Pricing Strategy

• Collaborate cross-functionally with Global teams in formulating and defining early-stage pricing and reimbursement strategies to support optimal access and reimbursement outcomes across all target regions. This includes inputting into and collaborating to help ensure a pricing architecture and launch sequence that reflects the value of our medicines.

• Build differentiated value narrative for key European markets and contribute to the development of the Global Value Dossier (GVD) and payer negotiation materials.

• Work closely with members of the Disease Area & Asset teams to help shape priority clinical development plans including single agent and combinations (both with standard of care medicines, other RevMed medicines and novel combinations).

• Work closely with Global teams to plan and execute country and regional payer and HTA advice as well as submissions.

• Identify and assess market access risks and opportunities in various EU countries, integrating them into product strategies and reflecting them in Target Product Profiles (TPPs).

• Partner with Clinical Development, HEOR and Regulatory Affairs to incorporate payer and patient relevant evidence into clinical development strategies.

• Collaborate closely with the HEOR team to ensure alignment between market access needs and health economic research plans for pipeline assets.

Launch Readiness & Market Engagement

• Work closely with the Global team to conduct European payer research and early engagement with HTA bodies (e.g., G-BA, NICE, HAS, AIFA, AEMPS, TLV, ZiNL, and others).

• Develop and maintain strong business relationships with key functions responsible for access with a focus on GMs, Country VAP teams, Clinical, Commercial, Regulatory, Medical Affairs, and HEOR stakeholders.

• Prepare and submit reimbursement and HTA dossiers in priority markets with clear alignment to clinical and economic evidence plans.

Cross-Functional and Team Leadership

• Partner with Global VAP, Medical Affairs, HEOR, Regulatory, and Clinical to align evidence generation with access and reimbursement needs.

• Build and lead a high-performing European Market Access team and coordinate closely with country teams to achieve reimbursement at prices that reflect the value of our medicines.

Policy, Risk & External Engagement

• Monitor and address European policy risks (e.g., international reference pricing, transparency laws, impact of MFN etc).

• Where appropriate, represent the company externally with payers, HTA bodies, trade associations, and policy groups, helping shape access environments.

Required Skills, Experience & Education:

• Bachelor’s degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA).

• Minimum 15 years of progressive leadership in market access, pricing, and reimbursement within the biopharma industry.

• Demonstrated success achieving reimbursement, pricing and launch success for a first-in-class or specialty therapy in European markets (especially Germany, France, UK etc).

• Demonstrated the ability to build and lead large multi-national teams in a global work environment needing to address and align different cultural value sets to a shared commercial strategy.

• Deep understanding of Europe payer systems and HTA processes, including JCA, AMNOG, NICE, and other EU frameworks.

• Experience designing and implementing pricing strategy, including value-based pricing, launch sequencing, and reference price mitigation throughout Europe.

• Proven ability to work cross-functionally and influence executive leadership in a dynamic, resource-constrained, early-stage company.

• Prior experience with European legislation and public policies that impact regional decisions.

• Experience working for or with external vendors, consultants, and access agencies to develop payer research, modeling, and dossier development.

• Strong executive presence, with the ability to clearly articulate complex value stories to both internal and external stakeholders.

• Strong communication skills in English, able to motivate and drive multi-national teams aligned with the overarching value framework of Revolution Medicines.

• Experience building or scaling European market access functions in a pre-commercial or newly commercial biotech company or within the biopharma industry.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.